Evgen Pharma Plc

Evgen Pharma (EVG)

Company name:Evgen Pharma Plc
Company Description:Evgen Pharma is a clinical stage drug development company whose lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke.
EPIC:EVGTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BSVYN304
Market Segment:ASQ1Share Type:DE
WWW Address:www.evgen.comDescription:ORD 0.25P
 Price Price Change [%] Bid Offer Open High Low Volume
 5.95 images.advfn.com/imagesnew/2/gb/dot 0.0 [0.00] 5.80 6.20 - - - -
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 16.36 274.89 0.01 -1.82 - - - 15.18 - 4.35

Evgen Pharma Key Figures

(at previous day's close)
Market Cap.16.36m
Shares In Issue274.89m
Prev. Close5.95
PE Ratio- 
Dividend Yield-%
EPS - basic-1.82p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-1.06p
Return On Equity (ROE)-22.64%
Operating Margin-1,656.19%
PEG Factor- 
EPS Growth Rate13.33%
Dividends PS Growth Rate-%
Net Debt-4.99m
Gross Gearing4.89%
Quick Assets12.35m
Net Working Capital11.74m
Intangibles / Fixed Assets92.96%
Turnover PS0.07p
Pre-Tax Profit PS-1.17p
Retained Profit PS-0.97p
Cash PS2.03p
Net Cash PS1.81p
Net Tangible Asset Value PS *4.27p
Net Asset Value PS4.30p
Spread0.40 (6.45%) 

Evgen Pharma Balance Sheet


Share Price Performance

Sample Period HighLow
1 week6.355.85
4 weeks8.205.85
12 weeks8.284.35
1 year15.184.35

Share Price Chart (5 years)

Evgen Pharma Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week5.900.050.855.850.586.15
4 weeks6.40-0.45-7.035.851.786.77
12 weeks8.05-2.10-26.094.352.295.78
26 weeks8.05-2.10-26.094.352.116.91
1 year11.43-5.48-47.924.351.888.29
3 years19.50-13.55-69.492.751.189.91
5 years30.00-24.05-80.172.750.8110.51

Evgen Pharma Key Management Ratios

Evgen Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 1.89 
Tobin's Q Ratio (excl. intangibles)1.91 
Dividend Yield-%
Market-to-Book Ratio1.38 
Price-to-Pre-Tax Profit PS-5.09 
Price-to-Retained Profit PS-6.12 
Price-to-Cash Flow PS-5.59 
Price-to-Sales PS84.31 
Price-to-Net Tangible Asset Value PS1.39 
Price-to-Cash PS2.92 
Net Working Capital PS4.27 
Price Pct to Working Capital PS1.39%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Evgen Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio-%
Debt-to-Equity Ratio- 
Debt-to-Equity Ratio (excl. Intgbl)- 
Debt-to-Equity Market Value- 
Net Gearing-40.15%
Net Gearing (excl. Intangibles)-40.37%
Gross Gearing4.89%
Gross Gearing (excl. Intangibles)4.91%
Gearing Under 1 Year4.89%
Gearing Under 1 Year (excl. Intgbl)4.91%
(Liquidity Ratios)
Net Working Capital to Total Assets94.54%
Current Ratio20.34 
Quick Ratio (Acid Test)20.34 
Liquidity Ratio9.21 
Cash & Equiv/Current Assets45.30%
(Solvency Ratios)
Enterprise Value10.76m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.04 
Total Debt/Sales3.13 
Total Debt/Pre-Tax Profit-0.19 
Total Debt0.61m
Total Debt/Net Current Assets0.05%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-12.75%
5 yr Compound Earnings Growth-15.36%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs- 
Beta (60-Mnth)Beta (36-Mnth)

Evgen Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-27.20%
Return On Assets (ROA)-30.96%
Net Profit Margin-1,378.35%
Assets Turnover0.02 
Return On Equity (ROE)-22.64%
Return On Investment (ROI)-33.39%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-1,378.35%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.02 
Fixed Assets Turnover2.50 
Current Assets Turnover0.02 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales44.52 
Debt Collection Period1,313.25Days

Evgen Pharma Dividends

Sorry No Data Available

Evgen Pharma Fundamentals

 31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)31 Mar 2021 (GBP)
pre tax profit-3.03--3.12--3.17--3.21-m
attributable profit-2.58--2.62--3.17--2.67-m
retained profit-2.58--2.62--3.17--2.67-m
eps - basic (p)-3.28 -2.74 -2.10 -1.82 
eps - diluted (p)-3.28 -2.74 -2.10 -1.82 
dividends per share- - - - 

Evgen Pharma Balance Sheet

 31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)31 Mar 2021 (GBP)
 31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)31 Mar 2021 (GBP)
fixed assets fixed assets0.010.28%0.010.22%0.000.04%0.010.04%m
intangibles intangibles0.112.65%0.103.55%0.081.69%0.070.53%m
fixed investments fixed investments--%--%--%--%m
current assets - other current assets - other--%--%--%6.0048.32%m
stocks stocks--%--%--%--%m
debtors debtors0.5111.95%0.6322.68%0.6413.22%0.756.07%m
cash & securities cash & securities3.6385.12%2.0373.55%4.1385.05%5.5945.04%m
creditors - short creditors - short0.399.13%0.6924.89%0.6513.44%0.614.89%m
creditors - long creditors - long--%--%--%--%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves3.8790.87%2.0875.11%4.2086.56%11.8195.11%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Evgen Pharma Cash Flow Statement

31 Mar 2018 (GBP)31 Mar 2019 (GBP)31 Mar 2020 (GBP)31 Mar 2021 (GBP)
Operating CF-2.34-2.29-2.58-2.93m
Pre-Financing CF-2.35-2.29-2.58-8.93m
Retained CF-0.23-1.592.101.46m

Evgen Pharma Brokers

Altium Capital LimitedMarket Maker(MME)Broker/DealerALTIAPCFGB21
Arden Partners PlcMarket Maker(MME)Broker/DealerARDAARRRGB2100A
Goldman Sachs InternationalMarket Maker(MME)Broker/DealerGSCOGSILGB2X
Canaccord Genuity LimitedMarket Maker(MME)Broker/DealerCANAHOARGB21001
Liberum Capital LimitedMarket Maker(MME)Broker/DealerLIBCLCAPGB21
Morgan Stanley Securities LtdMarket Maker(MME)Broker/DealerMOSTMSSEGB21
Citigrp Global Mkt UK EquitiesMarket Maker(MME)Broker/DealerCITISBUKGB21
Shore Capital Stockbrokers LtdMarket Maker(MME)Broker/DealerSCAPSHOCGB21
Merrill Lynch InternationalMarket Maker(MME)Broker/DealerMLSBSNCSGB2LBIC
UBS AGMarket Maker(MME)Broker/DealerUBS.UBSWGB2LEQU
Winterflood Securities LtdMarket Maker(MME)Broker/DealerWINSWNTSGB2LBIC
ADVFN Advertorial
Your Recent History
Evgen Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210923 07:09:22